Application 201801
- Type
- ANDA
- Sponsor
- EMCURE PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 5MG BASE/100ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201801-001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | EQ 5MG BASE/100ML | INJECTABLE / INTRAVENOUS | 2013-03-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-29 23:25 UTC | 2022-09 | A201801-001 | ZOLEDRONIC ACID | EQ 5MG BASE/100ML | INJECTABLE / INTRAVENOUS | 2013-03-29 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A201801-001 | ZOLEDRONIC ACID | EQ 5MG BASE/100ML | INJECTABLE / INTRAVENOUS | 2013-03-29 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A201801-001 | ZOLEDRONIC ACID | EQ 5MG BASE/100ML | INJECTABLE / INTRAVENOUS | 2013-03-29 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A201801-001 | AP | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A201801-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A201801-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A201801-001 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Zoledronic Acid | ZOLEDRONIC ACID | Meitheal Pharmaceuticals Inc. | 8aac81ae-f92c-4f0b-b480-44badf72b5f5 | 2026-07-09 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Eugia US LLC | bf5f96d4-f87c-4968-bed0-a4b5e77f4162 | 2026-05-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Mylan Institutional LLC | 80006f10-85a3-4390-b5dc-3b2097134f3d | 2026-03-18 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Mylan Institutional LLC | 1977d713-4cc7-405e-b4c1-a9a91635eff6 | 2026-03-16 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | Gland Pharma Limited | d761011b-edd6-4d3f-bacd-8607dc2414fc | 2026-02-27 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | FOSUN PHARMA USA INC | fd0324d8-b9bd-fd4c-e053-6394a90a5465 | 2026-02-26 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Gland Pharma Limited | 824eaeee-6b3d-4d62-b268-77f8bd8e7f10 | 2026-02-24 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Gland Pharma Limited | 46c3a880-3723-45cf-979e-57ef6391662e | 2026-02-06 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| Reclast | ZOLEDRONIC ACID | Sandoz Inc | 5a9b3737-9ce6-4a89-b76e-6aab79eba9cf | 2026-02-03 | Warnings, Adverse reactions | ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | BPI Labs LLC | 1b556f75-9174-4798-8c8d-21cf34beac13 | 2025-12-26 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | Accord Healthcare Inc. | 3df715a1-2562-4374-a383-6edc33c6e52f | 2025-10-08 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | BPI Labs LLC | 634e9d4b-e940-4743-ad39-794dad28d79b | 2025-10-03 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic acid | ZOLEDRONIC ACID | BluePoint Laboratories | f433c13c-dd8c-4dca-834e-a4ecf09d1eab | 2025-09-03 | Warnings, Adverse reactions | Zoledronic acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Sagent Pharmaceuticals | 567578e6-cd2d-4339-b0f6-7a15444c0639 | 2025-03-11 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| zoledronic acid | ZOLEDRONIC ACID | Sagent Pharmaceuticals | 164500d7-51cf-438a-8bee-7a7dce76ad7a | 2025-03-11 | Warnings, Adverse reactions | zoledronic acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Avenacy Inc. | 4b699dd8-d232-4bdb-88ce-9b42ed93e036 | 2025-01-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Gland Pharma Limited | 7a5e8962-7c4b-40bb-ad69-0c3edb0338af | 2023-11-15 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Inc. | bbb29627-76b5-e742-0e79-ef3bf22021b8 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Inc. | 72623e70-9db3-f1b8-de7d-c1a61d71fb01 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
| Zoledronic Acid | ZOLEDRONIC ACID | Dr. Reddy's Laboratories Limited | 1738a682-5903-b675-3a7a-61d299a6f248 | 2023-10-30 | Warnings, Adverse reactions | Zoledronic Acid ZOLEDRONIC ACID |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
Documents#
| Document | Submission type | Date |
|---|---|---|
| 22860 | ORIG | 2013-05-02 |